Clinical Efficacy or Tildrakizumab in Patients With Chronic Plaque Psoriasis Over 2 Years of Treatment: Results From Long-Term Extensions to 2 Phase 3 Clinical Studies

SKIN The Journal of Cutaneous Medicine

doi 10.25251/skin.2.supp.4